

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.43778696 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.43778696 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.26448693 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.26448693 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04958798 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.89708321 |
| 7 | response to host (GO:0075136) | 3.87073566 |
| 8 | response to host defenses (GO:0052200) | 3.87073566 |
| 9 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.87073566 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 3.85637217 |
| 11 | detection of other organism (GO:0098543) | 3.81929211 |
| 12 | pentose-phosphate shunt (GO:0006098) | 3.76715595 |
| 13 | NADPH regeneration (GO:0006740) | 3.73572650 |
| 14 | neutrophil activation (GO:0042119) | 3.71546646 |
| 15 | detection of bacterium (GO:0016045) | 3.65709307 |
| 16 | response to interferon-beta (GO:0035456) | 3.63633229 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 3.57510672 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 3.54957336 |
| 19 | regulation of mast cell degranulation (GO:0043304) | 3.52443693 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 3.52375728 |
| 21 | response to peptidoglycan (GO:0032494) | 3.52231100 |
| 22 | cellular response to type I interferon (GO:0071357) | 3.51958019 |
| 23 | type I interferon signaling pathway (GO:0060337) | 3.51958019 |
| 24 | response to type I interferon (GO:0034340) | 3.46861169 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43232832 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.43232832 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43232832 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43232832 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43232832 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.43232832 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 3.42173793 |
| 32 | detection of external biotic stimulus (GO:0098581) | 3.41415710 |
| 33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.41016511 |
| 34 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.40275629 |
| 35 | cellular response to interferon-beta (GO:0035458) | 3.38047513 |
| 36 | B cell mediated immunity (GO:0019724) | 3.37120656 |
| 37 | tachykinin receptor signaling pathway (GO:0007217) | 3.36099181 |
| 38 | regulation of interferon-alpha production (GO:0032647) | 3.35561103 |
| 39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.32463251 |
| 40 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.23238040 |
| 41 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.19332263 |
| 42 | regulation of leukocyte degranulation (GO:0043300) | 3.14707553 |
| 43 | response to interferon-alpha (GO:0035455) | 3.13365596 |
| 44 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.13325171 |
| 45 | regulation of superoxide anion generation (GO:0032928) | 3.13095026 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09171861 |
| 47 | leukocyte aggregation (GO:0070486) | 3.07592763 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.04758644 |
| 49 | respiratory burst (GO:0045730) | 2.99804286 |
| 50 | regulation of chemokine biosynthetic process (GO:0045073) | 2.99454226 |
| 51 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.99364419 |
| 52 | negative regulation of viral genome replication (GO:0045071) | 2.99098025 |
| 53 | DNA deamination (GO:0045006) | 2.97375239 |
| 54 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.97331313 |
| 55 | defense response to protozoan (GO:0042832) | 2.97271819 |
| 56 | cellular extravasation (GO:0045123) | 2.96125706 |
| 57 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.95770800 |
| 58 | pinocytosis (GO:0006907) | 2.93647752 |
| 59 | myeloid cell activation involved in immune response (GO:0002275) | 2.92917618 |
| 60 | positive regulation of interferon-beta production (GO:0032728) | 2.91830347 |
| 61 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.91555605 |
| 62 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.91371762 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 2.89988019 |
| 64 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87342227 |
| 65 | regulation of protein heterodimerization activity (GO:0043497) | 2.84957511 |
| 66 | formation of translation preinitiation complex (GO:0001731) | 2.82792797 |
| 67 | NIK/NF-kappaB signaling (GO:0038061) | 2.81505815 |
| 68 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80433937 |
| 69 | response to protozoan (GO:0001562) | 2.79758461 |
| 70 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.79155476 |
| 71 | protein maturation by protein folding (GO:0022417) | 2.77901773 |
| 72 | pyrimidine-containing compound salvage (GO:0008655) | 2.75913878 |
| 73 | pyrimidine nucleoside salvage (GO:0043097) | 2.75913878 |
| 74 | viral transcription (GO:0019083) | 2.75593830 |
| 75 | response to muramyl dipeptide (GO:0032495) | 2.74991579 |
| 76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74815751 |
| 77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.74202165 |
| 78 | cellular response to virus (GO:0098586) | 2.73524946 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.72654812 |
| 80 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.72532999 |
| 81 | positive regulation of mast cell activation (GO:0033005) | 2.69554983 |
| 82 | T cell migration (GO:0072678) | 2.68015970 |
| 83 | COPI coating of Golgi vesicle (GO:0048205) | 2.66102412 |
| 84 | Golgi transport vesicle coating (GO:0048200) | 2.66102412 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.65757616 |
| 86 | regulation of podosome assembly (GO:0071801) | 2.65144551 |
| 87 | regulation of regulated secretory pathway (GO:1903305) | 2.64688763 |
| 88 | response to interleukin-15 (GO:0070672) | 2.64619411 |
| 89 | natural killer cell mediated immunity (GO:0002228) | 2.64430261 |
| 90 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.64430261 |
| 91 | translational termination (GO:0006415) | 2.63765063 |
| 92 | glucose catabolic process (GO:0006007) | 2.63613690 |
| 93 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.62941301 |
| 94 | positive regulation of leukocyte degranulation (GO:0043302) | 2.62898186 |
| 95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62464575 |
| 96 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.62289887 |
| 97 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.61525265 |
| 98 | cellular response to exogenous dsRNA (GO:0071360) | 2.60952106 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 2.60072940 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.60072940 |
| 101 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59753324 |
| 102 | maturation of SSU-rRNA (GO:0030490) | 2.59099359 |
| 103 | cellular response to zinc ion (GO:0071294) | 2.58670835 |
| 104 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.58625442 |
| 105 | stress fiber assembly (GO:0043149) | 2.55744966 |
| 106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.55557253 |
| 107 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.55417827 |
| 108 | DNA strand elongation (GO:0022616) | 2.54920031 |
| 109 | regulation of defense response to virus by virus (GO:0050690) | 2.54854252 |
| 110 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.54550694 |
| 111 | negative regulation of phagocytosis (GO:0050765) | 2.53841308 |
| 112 | regulation of mast cell activation (GO:0033003) | 2.52721372 |
| 113 | glucose 6-phosphate metabolic process (GO:0051156) | 2.52697286 |
| 114 | myeloid dendritic cell differentiation (GO:0043011) | 2.52366951 |
| 115 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.51908025 |
| 116 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.49545860 |
| 117 | regulation of B cell differentiation (GO:0045577) | 2.49405593 |
| 118 | regulation of response to interferon-gamma (GO:0060330) | 2.48494913 |
| 119 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.48382499 |
| 120 | translational elongation (GO:0006414) | 2.48360139 |
| 121 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.47141150 |
| 122 | T cell apoptotic process (GO:0070231) | 2.45837369 |
| 123 | protein localization to endosome (GO:0036010) | 2.45470133 |
| 124 | macrophage activation (GO:0042116) | 2.44920464 |
| 125 | leukocyte degranulation (GO:0043299) | 2.43661873 |
| 126 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.43339848 |
| 127 | positive regulation of regulated secretory pathway (GO:1903307) | 2.43258912 |
| 128 | phospholipid scrambling (GO:0017121) | 2.42072097 |
| 129 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.41810663 |
| 130 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.41762323 |
| 131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.41099859 |
| 132 | protein targeting to ER (GO:0045047) | 2.38624365 |
| 133 | positive regulation of type I interferon production (GO:0032481) | 2.37969006 |
| 134 | cotranslational protein targeting to membrane (GO:0006613) | 2.37164774 |
| 135 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.36402769 |
| 136 | telomere maintenance via recombination (GO:0000722) | 2.35681944 |
| 137 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.33703076 |
| 138 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.33698723 |
| 139 | endosome to melanosome transport (GO:0035646) | 2.33434914 |
| 140 | endosome to pigment granule transport (GO:0043485) | 2.33434914 |
| 141 | response to host immune response (GO:0052572) | 2.33324288 |
| 142 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.33324288 |
| 143 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.33176245 |
| 144 | leukocyte mediated cytotoxicity (GO:0001909) | 2.32413101 |
| 145 | regulation of interferon-beta production (GO:0032648) | 2.30888734 |
| 146 | negative regulation of interleukin-12 production (GO:0032695) | 2.30121338 |
| 147 | DNA unwinding involved in DNA replication (GO:0006268) | 2.29635174 |
| 148 | myeloid dendritic cell activation (GO:0001773) | 2.29322613 |
| 149 | positive regulation of antigen processing and presentation (GO:0002579) | 2.28942620 |
| 150 | protein localization to endoplasmic reticulum (GO:0070972) | 2.27738235 |
| 151 | regulation of gamma-delta T cell activation (GO:0046643) | 2.27494010 |
| 152 | granulocyte activation (GO:0036230) | 2.26651372 |
| 153 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.26636613 |
| 154 | translational initiation (GO:0006413) | 2.24752367 |
| 155 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.23447230 |
| 156 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.22752449 |
| 157 | cellular response to interferon-gamma (GO:0071346) | 2.22220882 |
| 158 | ribosomal small subunit biogenesis (GO:0042274) | 2.22173434 |
| 159 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.20728344 |
| 160 | macrophage activation involved in immune response (GO:0002281) | 2.20714342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.05408922 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.57646947 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.26595568 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.13881769 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.93754106 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79816616 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.58777659 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.52031741 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41642137 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34586120 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.29559809 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.21601561 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.16527661 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.07051966 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03122852 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.02660302 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.99726844 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98306537 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.92538184 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.92507321 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91968848 |
| 22 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91645286 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89996418 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87786513 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.86458306 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86244235 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85578967 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80282037 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79847491 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77957492 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.77875360 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.76547073 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.75950883 |
| 34 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.75949054 |
| 35 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.74562142 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74465355 |
| 37 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.73590803 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73360038 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.70855273 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69823385 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.69783669 |
| 42 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.69724161 |
| 43 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.69371859 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67390451 |
| 45 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.62611075 |
| 46 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.60863622 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60828815 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58460314 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52887695 |
| 50 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.51502438 |
| 51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.50836974 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.50768391 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.50569680 |
| 54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49980743 |
| 55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.48561321 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.48302606 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48165414 |
| 58 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.47819345 |
| 59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46450345 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.46167232 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44946604 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.42694181 |
| 63 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42666475 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38996820 |
| 65 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38807406 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38203857 |
| 67 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37247119 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37110567 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36300183 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35302909 |
| 71 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.32445030 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31992898 |
| 73 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.29955972 |
| 74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29544455 |
| 75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29482266 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.28899077 |
| 77 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.28673656 |
| 78 | MYB_26560356_Chip-Seq_TH1_Human | 1.28398295 |
| 79 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25864122 |
| 80 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25645776 |
| 81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25459615 |
| 82 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25298225 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25274091 |
| 84 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.22773004 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20179359 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18359464 |
| 87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16125709 |
| 88 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15601568 |
| 89 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15446116 |
| 90 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15203186 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15147381 |
| 92 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.15083547 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14609487 |
| 94 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14511360 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13834726 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13731124 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13502974 |
| 98 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12757884 |
| 99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12180068 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11886233 |
| 101 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11595957 |
| 102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11544461 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11271821 |
| 104 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10841765 |
| 105 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.10669587 |
| 106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10191320 |
| 107 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09850411 |
| 108 | MAF_26560356_Chip-Seq_TH2_Human | 1.09840375 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09341375 |
| 110 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08867027 |
| 111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07951259 |
| 112 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.07736137 |
| 113 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07524924 |
| 114 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07403786 |
| 115 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07312715 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07063380 |
| 117 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06908582 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06317913 |
| 119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05885524 |
| 120 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.05522776 |
| 121 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.05039751 |
| 122 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04750080 |
| 123 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04099295 |
| 124 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04090724 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04081223 |
| 126 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03704494 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03355113 |
| 128 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03310933 |
| 129 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02872203 |
| 130 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02795961 |
| 131 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02236171 |
| 132 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02033745 |
| 133 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.01366405 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00151641 |
| 135 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.98535473 |
| 136 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98098734 |
| 137 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97548635 |
| 138 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.95608452 |
| 139 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95567031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.54447548 |
| 2 | MP0009785_altered_susceptibility_to | 3.49880786 |
| 3 | MP0008260_abnormal_autophagy | 3.48729106 |
| 4 | MP0003436_decreased_susceptibility_to | 3.44764960 |
| 5 | MP0005451_abnormal_body_composition | 2.78114289 |
| 6 | MP0000685_abnormal_immune_system | 2.73573469 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.66446421 |
| 8 | MP0005025_abnormal_response_to | 2.62463789 |
| 9 | MP0005671_abnormal_response_to | 2.54622995 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.52740471 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.49267440 |
| 12 | MP0002419_abnormal_innate_immunity | 2.41567581 |
| 13 | MP0001800_abnormal_humoral_immune | 2.34197118 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.30934743 |
| 15 | MP0005387_immune_system_phenotype | 2.30845453 |
| 16 | MP0001790_abnormal_immune_system | 2.30845453 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.26034890 |
| 18 | MP0006082_CNS_inflammation | 2.25439029 |
| 19 | MP0002723_abnormal_immune_serum | 2.22911789 |
| 20 | MP0001853_heart_inflammation | 2.18226161 |
| 21 | MP0003724_increased_susceptibility_to | 2.17653004 |
| 22 | MP0003303_peritoneal_inflammation | 2.15622738 |
| 23 | MP0001819_abnormal_immune_cell | 2.12880494 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.12212522 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.95785299 |
| 26 | MP0002398_abnormal_bone_marrow | 1.95573380 |
| 27 | MP0000858_altered_metastatic_potential | 1.92991679 |
| 28 | MP0002405_respiratory_system_inflammati | 1.87149970 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.85406757 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.84620462 |
| 31 | MP0000716_abnormal_immune_system | 1.78834074 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.78745079 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.78745079 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.77892762 |
| 35 | MP0003077_abnormal_cell_cycle | 1.76365249 |
| 36 | MP0004957_abnormal_blastocyst_morpholog | 1.73581751 |
| 37 | MP0004947_skin_inflammation | 1.73369067 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.70623642 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.69519585 |
| 40 | MP0009278_abnormal_bone_marrow | 1.68926258 |
| 41 | MP0008007_abnormal_cellular_replicative | 1.68833787 |
| 42 | MP0000490_abnormal_crypts_of | 1.68658992 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.67729209 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.67139719 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.66327904 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.65093148 |
| 47 | MP0002722_abnormal_immune_system | 1.64116078 |
| 48 | MP0002429_abnormal_blood_cell | 1.62547360 |
| 49 | MP0002006_tumorigenesis | 1.62274152 |
| 50 | MP0010094_abnormal_chromosome_stability | 1.60771676 |
| 51 | MP0009840_abnormal_foam_cell | 1.59907427 |
| 52 | MP0010307_abnormal_tumor_latency | 1.58780106 |
| 53 | MP0003111_abnormal_nucleus_morphology | 1.54317530 |
| 54 | MP0008057_abnormal_DNA_replication | 1.47754405 |
| 55 | MP0008469_abnormal_protein_level | 1.46088052 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.45832733 |
| 57 | MP0003448_altered_tumor_morphology | 1.44255084 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.43656641 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 1.37728945 |
| 60 | MP0000343_altered_response_to | 1.34476099 |
| 61 | MP0004510_myositis | 1.32738668 |
| 62 | MP0003186_abnormal_redox_activity | 1.32469390 |
| 63 | MP0008058_abnormal_DNA_repair | 1.30663700 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.28048726 |
| 65 | MP0000703_abnormal_thymus_morphology | 1.25584229 |
| 66 | MP0002019_abnormal_tumor_incidence | 1.21912491 |
| 67 | MP0004233_abnormal_muscle_weight | 1.18791361 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.18537204 |
| 69 | MP0009764_decreased_sensitivity_to | 1.16631969 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.16113359 |
| 71 | MP0002933_joint_inflammation | 1.12781586 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.12305089 |
| 73 | MP0003866_abnormal_defecation | 1.06609125 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.05581746 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 1.05544543 |
| 76 | MP0001873_stomach_inflammation | 1.04802935 |
| 77 | MP0005023_abnormal_wound_healing | 1.04182709 |
| 78 | MP0000313_abnormal_cell_death | 1.03620167 |
| 79 | MP0000678_abnormal_parathyroid_gland | 0.99831898 |
| 80 | MP0004858_abnormal_nervous_system | 0.93411172 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.92474462 |
| 82 | MP0009763_increased_sensitivity_to | 0.90318213 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.90014943 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.88944802 |
| 85 | MP0001851_eye_inflammation | 0.88456918 |
| 86 | MP0000350_abnormal_cell_proliferation | 0.88004104 |
| 87 | MP0003091_abnormal_cell_migration | 0.87290857 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.84752386 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.84724987 |
| 90 | MP0001915_intracranial_hemorrhage | 0.84680607 |
| 91 | MP0005390_skeleton_phenotype | 0.84430752 |
| 92 | MP0001849_ear_inflammation | 0.83946965 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.81712879 |
| 94 | MP0006054_spinal_hemorrhage | 0.81295003 |
| 95 | MP0005310_abnormal_salivary_gland | 0.80410743 |
| 96 | MP0004381_abnormal_hair_follicle | 0.78875523 |
| 97 | MP0005384_cellular_phenotype | 0.78856956 |
| 98 | MP0005164_abnormal_response_to | 0.76857665 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.76436847 |
| 100 | MP0000371_diluted_coat_color | 0.74871318 |
| 101 | MP0001730_embryonic_growth_arrest | 0.73761732 |
| 102 | MP0002796_impaired_skin_barrier | 0.73050743 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.72553041 |
| 104 | MP0006035_abnormal_mitochondrial_morpho | 0.71524976 |
| 105 | MP0005083_abnormal_biliary_tract | 0.71497876 |
| 106 | MP0000015_abnormal_ear_pigmentation | 0.71395588 |
| 107 | MP0002277_abnormal_respiratory_mucosa | 0.70041612 |
| 108 | MP0000598_abnormal_liver_morphology | 0.68932077 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.68923320 |
| 110 | MP0008004_abnormal_stomach_pH | 0.68345792 |
| 111 | MP0003075_altered_response_to | 0.67687001 |
| 112 | MP0005166_decreased_susceptibility_to | 0.67523612 |
| 113 | MP0008932_abnormal_embryonic_tissue | 0.67393519 |
| 114 | MP0002132_abnormal_respiratory_system | 0.65541617 |
| 115 | MP0000358_abnormal_cell_content/ | 0.65392866 |
| 116 | MP0005621_abnormal_cell_physiology | 0.62807975 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.62226221 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62164634 |
| 119 | MP0008873_increased_physiological_sensi | 0.59809425 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.59743555 |
| 121 | MP0003828_pulmonary_edema | 0.59654532 |
| 122 | MP0000604_amyloidosis | 0.58472779 |
| 123 | MP0002080_prenatal_lethality | 0.58414028 |
| 124 | MP0000477_abnormal_intestine_morphology | 0.57820275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.21056285 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.08861973 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.76075567 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.44093113 |
| 5 | Myositis (HP:0100614) | 4.24642549 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.95962351 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 3.81888024 |
| 8 | Episodic fever (HP:0001954) | 3.72804790 |
| 9 | Thrombocytosis (HP:0001894) | 3.71810606 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.69056137 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.49463478 |
| 12 | Orchitis (HP:0100796) | 3.43331822 |
| 13 | Petechiae (HP:0000967) | 3.34663795 |
| 14 | Cholecystitis (HP:0001082) | 3.33744631 |
| 15 | Abnormal gallbladder physiology (HP:0012438) | 3.33744631 |
| 16 | Chronic otitis media (HP:0000389) | 3.31465322 |
| 17 | Loss of speech (HP:0002371) | 3.28228259 |
| 18 | Interstitial pulmonary disease (HP:0006530) | 3.22748274 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.17694103 |
| 20 | Recurrent viral infections (HP:0004429) | 3.04292946 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.03770750 |
| 22 | Agnosia (HP:0010524) | 2.98412465 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.94252729 |
| 24 | Obstructive lung disease (HP:0006536) | 2.94252729 |
| 25 | Vasculitis (HP:0002633) | 2.86915657 |
| 26 | Basal ganglia calcification (HP:0002135) | 2.83748023 |
| 27 | Recurrent skin infections (HP:0001581) | 2.78567795 |
| 28 | Cellulitis (HP:0100658) | 2.77706252 |
| 29 | IgM deficiency (HP:0002850) | 2.71235698 |
| 30 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.69413963 |
| 31 | Recurrent bronchitis (HP:0002837) | 2.69178657 |
| 32 | Stomatitis (HP:0010280) | 2.65589278 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.64462232 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.64462232 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.64462232 |
| 36 | Poor head control (HP:0002421) | 2.63526149 |
| 37 | Aplastic anemia (HP:0001915) | 2.62888416 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61778463 |
| 39 | Mucopolysacchariduria (HP:0008155) | 2.61778463 |
| 40 | Increased IgE level (HP:0003212) | 2.61699725 |
| 41 | Nasal polyposis (HP:0100582) | 2.61091921 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 2.59981155 |
| 43 | Optic neuritis (HP:0100653) | 2.59981155 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.59624275 |
| 45 | Degeneration of anterior horn cells (HP:0002398) | 2.56162716 |
| 46 | Abnormality of the anterior horn cell (HP:0006802) | 2.56162716 |
| 47 | Abnormality of the nasal mucosa (HP:0000433) | 2.56004214 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.52165704 |
| 49 | Gingivitis (HP:0000230) | 2.51345740 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.51331597 |
| 51 | Amyloidosis (HP:0011034) | 2.50401944 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.46163169 |
| 53 | Reticulocytopenia (HP:0001896) | 2.45478529 |
| 54 | Abnormality of T cells (HP:0002843) | 2.45357073 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.41548379 |
| 56 | Periodontitis (HP:0000704) | 2.40827691 |
| 57 | Meningitis (HP:0001287) | 2.36933731 |
| 58 | Long palpebral fissure (HP:0000637) | 2.36101496 |
| 59 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.31625244 |
| 60 | Pustule (HP:0200039) | 2.30077829 |
| 61 | Peritonitis (HP:0002586) | 2.29264484 |
| 62 | Encephalitis (HP:0002383) | 2.27792852 |
| 63 | Increased IgM level (HP:0003496) | 2.26064979 |
| 64 | Progressive neurologic deterioration (HP:0002344) | 2.25113160 |
| 65 | Leukocytosis (HP:0001974) | 2.24857854 |
| 66 | Type I transferrin isoform profile (HP:0003642) | 2.23556952 |
| 67 | Purpura (HP:0000979) | 2.22071130 |
| 68 | Upper motor neuron abnormality (HP:0002127) | 2.22053228 |
| 69 | Urticaria (HP:0001025) | 2.21046651 |
| 70 | Abnormal number of erythroid precursors (HP:0012131) | 2.19050792 |
| 71 | Pallor (HP:0000980) | 2.16366332 |
| 72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.16350493 |
| 73 | Abnormality of the peritoneum (HP:0002585) | 2.16050780 |
| 74 | Gingival bleeding (HP:0000225) | 2.15870650 |
| 75 | * Lymphoma (HP:0002665) | 2.14120925 |
| 76 | Nausea (HP:0002018) | 2.13417143 |
| 77 | Lymphopenia (HP:0001888) | 2.12841253 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 2.12462747 |
| 79 | Hypophosphatemic rickets (HP:0004912) | 2.08894409 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 2.07918765 |
| 81 | Osteomyelitis (HP:0002754) | 2.07393588 |
| 82 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06975115 |
| 83 | Vertebral compression fractures (HP:0002953) | 2.06007311 |
| 84 | Amaurosis fugax (HP:0100576) | 2.05929359 |
| 85 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05190590 |
| 86 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05190590 |
| 87 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05190590 |
| 88 | Deep venous thrombosis (HP:0002625) | 2.03111330 |
| 89 | Granulocytopenia (HP:0001913) | 2.01841465 |
| 90 | Pulmonary infiltrates (HP:0002113) | 2.01763207 |
| 91 | Cervical subluxation (HP:0003308) | 2.01399236 |
| 92 | Systemic lupus erythematosus (HP:0002725) | 2.01267155 |
| 93 | IgG deficiency (HP:0004315) | 2.01015090 |
| 94 | Hemoptysis (HP:0002105) | 1.99397125 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98867426 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98867426 |
| 97 | Dysostosis multiplex (HP:0000943) | 1.98115350 |
| 98 | Myocardial infarction (HP:0001658) | 1.97804169 |
| 99 | Increased serum ferritin (HP:0003281) | 1.96719676 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 1.95727982 |
| 101 | Progressive external ophthalmoplegia (HP:0000590) | 1.94203345 |
| 102 | Anorexia (HP:0002039) | 1.93775278 |
| 103 | Epistaxis (HP:0000421) | 1.93272869 |
| 104 | Hepatosplenomegaly (HP:0001433) | 1.93025646 |
| 105 | * Skin ulcer (HP:0200042) | 1.92030260 |
| 106 | Neuronal loss in central nervous system (HP:0002529) | 1.91927344 |
| 107 | Eosinophilia (HP:0001880) | 1.91901735 |
| 108 | Metaphyseal cupping (HP:0003021) | 1.91636044 |
| 109 | Multiple enchondromatosis (HP:0005701) | 1.91289612 |
| 110 | Menorrhagia (HP:0000132) | 1.90852782 |
| 111 | Abnormal platelet volume (HP:0011876) | 1.86987589 |
| 112 | Abnormality of the pleura (HP:0002103) | 1.86759292 |
| 113 | Cutaneous melanoma (HP:0012056) | 1.86690513 |
| 114 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86591128 |
| 115 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.85896446 |
| 116 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.85896446 |
| 117 | Abnormal protein glycosylation (HP:0012346) | 1.85896446 |
| 118 | Abnormal glycosylation (HP:0012345) | 1.85896446 |
| 119 | Gastrointestinal dysmotility (HP:0002579) | 1.85469993 |
| 120 | Broad face (HP:0000283) | 1.84721239 |
| 121 | Glomerulopathy (HP:0100820) | 1.83173900 |
| 122 | Albinism (HP:0001022) | 1.83059628 |
| 123 | Chest pain (HP:0100749) | 1.81465469 |
| 124 | Leukopenia (HP:0001882) | 1.81205142 |
| 125 | Hypertensive crisis (HP:0100735) | 1.80844664 |
| 126 | Upper limb amyotrophy (HP:0009129) | 1.80342910 |
| 127 | Distal upper limb amyotrophy (HP:0007149) | 1.80342910 |
| 128 | 11 pairs of ribs (HP:0000878) | 1.80159915 |
| 129 | * Rough bone trabeculation (HP:0100670) | 1.80130340 |
| 130 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80116902 |
| 131 | * Neutropenia (HP:0001875) | 1.80030321 |
| 132 | Hand muscle atrophy (HP:0009130) | 1.79858739 |
| 133 | Inflammation of the large intestine (HP:0002037) | 1.79602689 |
| 134 | Spontaneous hematomas (HP:0007420) | 1.78212753 |
| 135 | Arterial thrombosis (HP:0004420) | 1.77986502 |
| 136 | Prolonged bleeding time (HP:0003010) | 1.77621464 |
| 137 | Axonal loss (HP:0003447) | 1.77169751 |
| 138 | Entropion (HP:0000621) | 1.76762402 |
| 139 | Abnormality of T cell number (HP:0011839) | 1.76170038 |
| 140 | Increased density of long bones (HP:0006392) | 1.75813052 |
| 141 | Polygenic inheritance (HP:0010982) | 1.75276945 |
| 142 | Gastrointestinal stroma tumor (HP:0100723) | 1.74744915 |
| 143 | Abnormality of eosinophils (HP:0001879) | 1.74492828 |
| 144 | * Hypermelanotic macule (HP:0001034) | 1.73286404 |
| 145 | Emphysema (HP:0002097) | 1.73042467 |
| 146 | Elevated alkaline phosphatase (HP:0003155) | 1.72874484 |
| 147 | Keratoconjunctivitis (HP:0001096) | 1.71670217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.47587344 |
| 2 | ERN1 | 3.00156752 |
| 3 | SIK3 | 2.82405077 |
| 4 | PIM2 | 2.76282010 |
| 5 | TBK1 | 2.62902801 |
| 6 | TYK2 | 2.49295492 |
| 7 | KIT | 2.41023216 |
| 8 | ICK | 2.40444576 |
| 9 | NME2 | 2.32614390 |
| 10 | BUB1 | 2.29924855 |
| 11 | SMG1 | 2.27650636 |
| 12 | TXK | 2.11865867 |
| 13 | IKBKE | 2.11446580 |
| 14 | BLK | 2.08809879 |
| 15 | JAK3 | 2.08241752 |
| 16 | ZAP70 | 2.01689625 |
| 17 | RPS6KA4 | 1.99688022 |
| 18 | ACVR1B | 1.95383370 |
| 19 | FLT3 | 1.94368873 |
| 20 | MAP3K14 | 1.93563615 |
| 21 | PRPF4B | 1.91226132 |
| 22 | IRAK4 | 1.85900186 |
| 23 | TAOK1 | 1.84207314 |
| 24 | TESK2 | 1.82063998 |
| 25 | TGFBR1 | 1.78952175 |
| 26 | IRAK3 | 1.71492072 |
| 27 | PKN2 | 1.70858049 |
| 28 | KSR2 | 1.70434912 |
| 29 | STK16 | 1.69095585 |
| 30 | FGR | 1.65800038 |
| 31 | WEE1 | 1.56897804 |
| 32 | IKBKB | 1.56422606 |
| 33 | CDK8 | 1.45118980 |
| 34 | DYRK3 | 1.44509843 |
| 35 | EEF2K | 1.43369013 |
| 36 | NEK2 | 1.43052948 |
| 37 | BTK | 1.39932901 |
| 38 | LRRK2 | 1.32457662 |
| 39 | STK10 | 1.30863959 |
| 40 | CSF1R | 1.30254341 |
| 41 | KDR | 1.28815097 |
| 42 | FGFR4 | 1.27643597 |
| 43 | MAP2K3 | 1.27016111 |
| 44 | SIK1 | 1.25908001 |
| 45 | TESK1 | 1.21540037 |
| 46 | TEC | 1.20832707 |
| 47 | EIF2AK1 | 1.20608716 |
| 48 | SYK | 1.17850280 |
| 49 | VRK2 | 1.17770518 |
| 50 | MAP3K10 | 1.17743816 |
| 51 | PIM1 | 1.17210155 |
| 52 | PRKD2 | 1.12540141 |
| 53 | BRSK2 | 1.09597639 |
| 54 | TNK2 | 1.08132543 |
| 55 | CHUK | 1.05118662 |
| 56 | PAK4 | 1.02421259 |
| 57 | MAP3K11 | 0.98072112 |
| 58 | CSK | 0.94726823 |
| 59 | RPS6KB2 | 0.94279969 |
| 60 | EIF2AK3 | 0.94201716 |
| 61 | CDC7 | 0.93414482 |
| 62 | PBK | 0.93362548 |
| 63 | ARAF | 0.92989096 |
| 64 | TGFBR2 | 0.91455341 |
| 65 | MAP3K1 | 0.91056713 |
| 66 | SIK2 | 0.88451157 |
| 67 | CDK4 | 0.87171016 |
| 68 | ATR | 0.86923641 |
| 69 | TRIB3 | 0.86224077 |
| 70 | HCK | 0.85842074 |
| 71 | KSR1 | 0.85195865 |
| 72 | PASK | 0.84977191 |
| 73 | LIMK1 | 0.84333293 |
| 74 | LYN | 0.83587972 |
| 75 | CDK7 | 0.82699555 |
| 76 | YES1 | 0.82484755 |
| 77 | CDK9 | 0.82373227 |
| 78 | SCYL2 | 0.81529050 |
| 79 | LCK | 0.81408804 |
| 80 | JAK1 | 0.77801853 |
| 81 | MAP3K13 | 0.76196722 |
| 82 | CDK12 | 0.75015643 |
| 83 | FES | 0.74926696 |
| 84 | ERBB4 | 0.74881964 |
| 85 | MAP3K8 | 0.74635715 |
| 86 | STK4 | 0.72973832 |
| 87 | PRKG2 | 0.72031562 |
| 88 | RAF1 | 0.69763184 |
| 89 | DAPK1 | 0.69645472 |
| 90 | STK38 | 0.69570885 |
| 91 | TSSK6 | 0.68964461 |
| 92 | MAP3K6 | 0.68875957 |
| 93 | CDC42BPA | 0.68314257 |
| 94 | PTK6 | 0.67228510 |
| 95 | MATK | 0.67156572 |
| 96 | GRK6 | 0.67073371 |
| 97 | TRIM28 | 0.64977047 |
| 98 | AURKB | 0.63028925 |
| 99 | PLK4 | 0.62177558 |
| 100 | ABL2 | 0.59007184 |
| 101 | PTK2 | 0.58632434 |
| 102 | PLK1 | 0.58056725 |
| 103 | MARK2 | 0.57288050 |
| 104 | ITK | 0.56452077 |
| 105 | EIF2AK2 | 0.56256559 |
| 106 | ILK | 0.55229462 |
| 107 | ALK | 0.54884052 |
| 108 | BMPR1B | 0.53936221 |
| 109 | RIPK4 | 0.53464894 |
| 110 | RPS6KA5 | 0.52452145 |
| 111 | TAOK2 | 0.50040148 |
| 112 | MST1R | 0.49744934 |
| 113 | BMX | 0.48301114 |
| 114 | EPHB1 | 0.48274726 |
| 115 | BRSK1 | 0.47831647 |
| 116 | MOS | 0.47587837 |
| 117 | EPHA2 | 0.46868223 |
| 118 | NTRK1 | 0.45747566 |
| 119 | TTN | 0.45700613 |
| 120 | RPS6KA6 | 0.45364081 |
| 121 | CAMKK2 | 0.45195091 |
| 122 | MAPKAPK2 | 0.45066668 |
| 123 | CLK1 | 0.44910881 |
| 124 | EPHA3 | 0.44149450 |
| 125 | SRPK1 | 0.44122062 |
| 126 | PAK1 | 0.43129111 |
| 127 | MAP3K5 | 0.42112921 |
| 128 | MAP3K9 | 0.41818041 |
| 129 | PDPK1 | 0.41502322 |
| 130 | MAP2K6 | 0.41303801 |
| 131 | MARK3 | 0.40365198 |
| 132 | CSNK1A1L | 0.39987496 |
| 133 | PIK3CG | 0.39744401 |
| 134 | JAK2 | 0.38911789 |
| 135 | CDK6 | 0.38651266 |
| 136 | BRAF | 0.37494297 |
| 137 | MAP3K3 | 0.36017618 |
| 138 | FGFR3 | 0.35645760 |
| 139 | RPS6KL1 | 0.31677969 |
| 140 | RPS6KC1 | 0.31677969 |
| 141 | FYN | 0.30015039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.84858704 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.79388430 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54081279 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.48807599 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.30102723 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.17078791 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14973603 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.10957956 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08235969 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 1.94935156 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91049528 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.89038949 |
| 13 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.85890232 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85861588 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73911859 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66458625 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64420340 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.61377897 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.60203441 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.56163187 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.51951534 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.51909935 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.51719630 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.48783550 |
| 25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.48763817 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48489002 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.46553595 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.46460894 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46028086 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.42567489 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.35615200 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.34943098 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.34484471 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.31247777 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29493956 |
| 36 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.25150552 |
| 37 | RNA transport_Homo sapiens_hsa03013 | 1.24810895 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.24757841 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23457159 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22749387 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22706775 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.22586650 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 1.22237234 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20807183 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.19412429 |
| 46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.18596374 |
| 47 | Cell cycle_Homo sapiens_hsa04110 | 1.17907201 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17496761 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16462082 |
| 50 | Endocytosis_Homo sapiens_hsa04144 | 1.14210533 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.12886006 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10833097 |
| 53 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.09460929 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 1.08306013 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 1.05400015 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04891796 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.03982610 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02123926 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.01592125 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01343906 |
| 61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.97977902 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97128314 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96306454 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93782631 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93759859 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89982828 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.89862979 |
| 68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.88923044 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86952837 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.85232429 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.82847466 |
| 72 | Protein export_Homo sapiens_hsa03060 | 0.82678489 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81478961 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81289217 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80645566 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80554842 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78200958 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77461226 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.76047928 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76002616 |
| 81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75673762 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75497937 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75292213 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75048638 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74244464 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73847808 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72212913 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70596526 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70003521 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67219248 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64587579 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64344571 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64296971 |
| 94 | Adherens junction_Homo sapiens_hsa04520 | 0.63415577 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63245311 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.62062565 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61352771 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60605787 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60516940 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60325679 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59467677 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59404984 |
| 103 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58922965 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57414336 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57344247 |
| 106 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56857492 |
| 107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.55973028 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55786339 |
| 109 | Basal transcription factors_Homo sapiens_hsa03022 | 0.54959339 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53703691 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53487879 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53304143 |
| 113 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51971159 |
| 114 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51426589 |
| 115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50844345 |
| 116 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50414338 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48885721 |
| 118 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47371803 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47365610 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47338155 |
| 121 | Purine metabolism_Homo sapiens_hsa00230 | 0.45777803 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45377479 |
| 123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45266043 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42936060 |
| 125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40660472 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38970291 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38489670 |
| 128 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.37080367 |

